Molecule Details
| InChIKey | ZQTAUZWIZMXKIL-XZOQPEGZSA-N |
|---|---|
| Compound Name | N-cyclopropyl-4-oxo-1-[3-[4-[(1R,2R)-2-(2H-tetrazol-5-yl)cyclopropyl]phenyl]phenyl]-1,8-naphthyridine-3-carboxamide |
| Canonical SMILES | O=C(NC1CC1)c1cn(-c2cccc(-c3ccc([C@@H]4C[C@H]4c4nnn[nH]4)cc3)c2)c2ncccc2c1=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 9.26 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P27815 | PDE4A | Homo sapiens | Human | PF18100 PF00233 | 9.3 | IC50 | ChEMBL |
| Q07343 | PDE4B | Homo sapiens | Human | PF18100 PF00233 | 9.3 | IC50 | ChEMBL |
| Q08493 | PDE4C | Homo sapiens | Human | PF18100 PF00233 | 9.3 | IC50 | ChEMBL |
| Q08499 | PDE4D | Homo sapiens | Human | PF18100 PF00233 | 9.3 | IC50 | ChEMBL |